Rapid in vivo multiplexed editing (RIME) of the adult mouse liver
preprint
OA: closed
CC-BY-NC-ND-4.0
AI-generated summary
This study developed Rapid in vivo Multiplexed Editing (RIME) using CRISPR/Cas9 and AAVs to efficiently and rapidly inactivate multiple genes in the adult mouse liver.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Background & Aims Assessing mammalian gene function in vivo has traditionally relied on manipulation of the mouse genome in embryonic stem cells or peri-zygotic embryos. These approaches are time consuming and require extensive breeding when simultaneous mutations in multiple genes is desired. The aim of this study is to introduce a R apid I n vivo M ultiplexed Editing (RIME), and to provide a proof-of-concept of this system. Approach & Results RIME, a system wherein CRISPR/Cas9 technology, paired with adeno-associated viruses (AAVs), permits the inactivation of one or more genes in the adult mouse liver. The method is quick, requiring as little as 1 month from conceptualization to knockout (KO), and highly efficient, enabling editing in >95% of target cells. To highlight its utility, we used this system to inactivate, alone or in combination, genes with functions spanning metabolism, mitosis, mitochondrial maintenance, and cell proliferation. Conclusion RIME enables the rapid, efficient, and inexpensive analysis of multiple genes in the mouse liver in vivo .
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-30T02:00:01.510937+00:00
License: CC-BY-NC-ND-4.0